| Patient | Theodore Roosevelt |
|---|---|
| Date of birth | 1858-10-27 |
| Identifiers | MRN HR-NI012-SYN-TD; SSN (made up) 000-12-6157 |
| Document date | 1882-10-19 |
| Author | Amos Kettering, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Adult preventive visit; no new complaints. [S]
Mr. Roosevelt returns for his yearly preventive visit, five weeks after his six-month asthma review. He has had no further exacerbations since the August cold, no night waking, and uses one reliever inhalation before boxing or rowing and rarely otherwise. He trains five days a week. He has no new concerns. He reports good adherence to his maintenance inhaler and keeps a weekly peak-flow record in the green zone. His last eye examination was more than two years ago and his glasses feel weaker for distance. [S]
| Element | Detail |
|---|---|
| Visit | Periodic preventive visit, age 23 |
| Asthma since last visit | No exacerbations; reliever before exercise only; peak flow in the green zone |
| Vision | Distance glasses feel weaker; last eye examination more than two years ago |
| Medicines | Budesonide-formoterol maintenance and as needed; no other medicines or supplements |
| Safety events | No injuries, emergency visits, or hospital stays |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Excellent |
| Physical activity | Boxing three times a week, rowing, and long weekend hill walks; more than 300 minutes of activity a week |
| Diet | Large appetite; mixed diet with fruit and vegetables most days |
| Tobacco and nicotine | Never smoked or vaped; avoids smoky rooms |
| Alcohol and drugs | Rare alcohol (AUDIT-C 1); no drug use |
| Sleep | Six to seven hours on session nights; no snoring or daytime sleepiness |
| Psychosocial | Busy and engaged at work; good friendships; no loneliness |
| Injury and safety | Wears a seat belt; uses headgear and a mouthguard when sparring; no firearms at home |
| Sun exposure | Long hours outdoors on hill walks and on the water; rarely uses sunscreen |
| Sexual health | One partner; no concerns |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever, night sweats, or fatigue |
| Eyes | Positive | Distance vision blurrier with his current glasses; no eye pain or redness |
| Ears, nose, mouth, and throat | Negative | No nasal blockage, hearing loss, or dental pain |
| Respiratory | Negative | No cough, night symptoms, or wheeze; reliever before exercise only |
| Cardiovascular | Negative | No chest pain, palpitations, or exertional fainting |
| Gastrointestinal | Negative | No heartburn, reflux, or change in bowel habit |
| Genitourinary | Negative | No urinary symptoms |
| Musculoskeletal | Negative | No joint pain or injuries from training |
| Integumentary | Negative | No new or changing moles |
| Neurological | Negative | No headaches, dizziness, or numbness |
| Psychiatric | Negative | Mood good; sleeps well; PHQ-2 score 0 |
| Endocrine | Negative | No heat or cold intolerance, thirst, or polyuria |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Albuterol 90 mcg/actuation inhaler, two inhalations as needed for wheeze (bought after an urgent care visit; used most days before intake) | Two inhalations every 4 hours as needed | Respiratory tract route | 1881-12-15 to 1882-03-09 | stopped | S |
| Budesonide-formoterol 160/4.5 mcg inhaler, two inhalations twice daily for maintenance | Two inhalations twice daily, with a spacer, rinsing the mouth afterwards | Respiratory tract route | 1882-03-09 | active | S |
| Budesonide-formoterol 160/4.5 mcg inhaler, one inhalation as needed for symptoms and before exercise; no more than 12 inhalations a day in total | One inhalation as needed, repeated after a few minutes if needed; maximum 12 inhalations a day including maintenance doses | Respiratory tract route | 1882-03-09 | active | S |
| Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning for 5 days | Two tablets by mouth each morning for 5 days | Oral route | 1882-08-03 to 1882-08-07 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1882-10-19 | Body height | 175 | cm | S |
| 1882-10-19 | Body weight | 73.5 | kg | S |
| 1882-10-19 | Body mass index (BMI) [Ratio] | 24 | kg/m2 | S |
| 1882-10-19 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1882-10-19 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1882-10-19 | Heart rate | 66 | /min | S |
| 1882-10-19 | Respiratory rate | 14 | /min | S |
| 1882-10-19 | Body temperature | 36.6 | Cel | S |
| 1882-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1882-10-19 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1882-10-19 | Total score [AUDIT-C] | 1 | {score} | S |
Vital signs recorded on 1882-10-19; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well, muscular build; BMI 24.0 |
| Eyes | Distance acuity 20/40 in each eye with current glasses; pupils equal and reactive; fundi normal |
| Ears, nose, and throat | Canals and drums normal; nasal mucosa normal; no polyps |
| Neck | No lymph nodes or thyroid enlargement |
| Respiratory | Clear, with no wheeze on forced expiration |
| Cardiovascular | Regular rhythm; no murmur at rest or on standing |
| Abdomen | Soft and non-tender |
| Skin | Several benign-appearing nevi on the back and arms; no suspicious lesions |
| Psychiatric | Cheerful and engaged |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Moderate persistent asthma, uncontrolled at intake, with reversible airflow obstruction on spirometry; synthetic modern diagnosis linked to his documented lifelong asthma | active | confirmed | J45.40 | S — Synthetic modern classification confirmed by spirometry; the historical asthma is D and its persistence into adulthood is R. |
| Myopia, both eyes, corrected with glasses since boyhood | active | confirmed | H52.13 | S — Synthetic modern entry linked to his documented near-sightedness. |
| Moderate asthma exacerbation triggered by a viral cold, treated in the office with a five-day prednisone course; resolved | resolved | confirmed | J45.41 | S — Synthetic exacerbation at an unscheduled visit; viral infection is the most common trigger of asthma exacerbations. It does not echo a dated historical episode. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, this season | Completed today | Given today; recommended every year, and especially with asthma |
| COVID-19 vaccine, this season | Due | Discussed under current CDC guidance for adults with chronic lung disease; he will get it at his pharmacy |
| Pneumococcal vaccine | Up to date | PCV20 given at his four-week asthma review for chronic lung disease; no further doses needed |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap seven years ago; next booster due in three years |
| HPV vaccine | Up to date | Two-dose series completed in adolescence |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 1 |
| Tobacco use | Completed today | Never used tobacco or nicotine; advised to keep avoiding smoke, a key asthma trigger |
| Blood pressure screening | Completed today | 118/70 mmHg; recheck every three to five years |
| HIV screening | Ordered | One-time antigen and antibody test, with his consent; no prior result on record |
| Hepatitis C screening | Ordered | One-time antibody test with reflex RNA, with his consent |
| Skin cancer prevention counseling | Completed today | Recommended for fair-skinned people up to age 24; sun protection advice given |
| Eye examination | Referred | Optometry referral for refraction |
| Lipid and diabetes screening | Not indicated | No risk factors; diabetes screening starts at 35 for adults with overweight or obesity |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never smoker, and below the screening ages |
Immunizations given today: Influenza vaccine, 1882-1883 season [S]
Guideline basis: CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026)
Follow-up: HIV and hepatitis C tests with his next blood draw. Optometry referral. Asthma review in about three months. Next preventive visit in one year. [S]
Voluntary advance care planning discussion of about 16 minutes, with his consent. He has not written an advance directive before. He chose a health care agent and was given the state form to complete; he will bring a copy back for the chart. He wants full treatment, including intensive care and mechanical ventilation, for a severe asthma attack or any other reversible illness. [S]